Biocracked
Approach: the human outcome (a blood pressure reading in a real setting). Palette: D, bold color field.

Tight, slightly high-angle close-up of a bare upper arm wrapped in a matte charcoal blood pressure cuff, with the rubber tube curving across the frame. The arm rests on a table against a saturated tomato-red backdrop. A hand with a clean white sleeve cuff holds a stethoscope chest piece at the inner elbow. The face is out of frame. Soft, diffuse studio light from the upper left gives the skin natural warmth and subtle texture. The shadows are gentle, warm and reddish, with no blue cast. A small electric green (#00e676) digital gauge needle or LED glows on the cuff's inflation bulb, tucked in the lower right. The shallow depth of field blurs the background edges. The mood is clinical but bold, cautious and questioning, a measured result under scrutiny.
Supplements

NOVOS Core Nganggo Tekanan Darah Mudhun 6 mmHg: Apa Sing Kudune Dikenal

Nova Chen · · 4 min read

Bubuk sing dicampur ing omben‑omben saben dina, ngandhut 12 bahan, lan dilaporke ing jurnal kardiologi, nuduhake fungsi arteri luwih apik sawise enem wulan. Kuwi versi ringkes saka trial acak anyar babagan NOVOS Core. Gambaran lengkapé luwih jujur lan luwih ati‑ati tinimbang versi sing dimarketingake.

Studi iki, sing dipublikasikaké ing European Heart Journal Open, iku trial acak double‑blind sing dilakokaké dening University of Surrey lan tim NHS sing kerjasama. Iki sing ditemokaké, apa sing ora ditemokaké, lan sapa sing kudu peduli.

Poin‑poin Utama

  • Fungsi endotel (flow‑mediated dilation, FMD): asil utama nambah 2,9 % poin (95 % CI 2,1 nganti 3,8).
  • Kekakuan arteri (pulse wave velocity, PWV): mudhun 1,18 m/s (95 % CI –2,00 nganti –0,36).
  • Tekanan darah sistolik (SBP) periferal: mudhun 6,1 mmHg (95 % CI –10,9 nganti –1,3).
  • Risiko kardiovaskular 10 taun (SCORE2/SCORE2‑OP): mudhun 0,45 % poin (95 % CI –0,86 nganti –0,03).
  • Lipid: ora owah.

FMD ngukur sepira apik lapisan njero arteri (endotel) bisa relaksasi nalika aliran darah nambah, lan dadi ukuran kesehatan endotel sing umum dipigunakaké. PWV ngukur kecepatan gelombang nadi ngliwati arteri; kecepatan sing luwih dhuwur nuduhaké pembuluh sing luwih kaku. Kabeh loro iki mung penanda surrogate, dudu kejadian nyata kaya serangan jantung utawa stroke.

Kejutan: Bukan Kolesterol

Akeh suplemen sing dipuji amarga "kesehatan jantung" liwat perubahan lipid. Suplemen iki ora mengaruhi lipid. Penulis ngaitaké penurunan cilik ing risiko kardiovaskular utama marang tekanan darah sistolik sing luwih rendah, amarga perhitungan SCORE2 gumantung banget marang SBP, umur, jenis kelamin, rokok, lan kolesterol. Yen lipid tetep datar, tekanan darah dadi faktor utama sing bisa ngowahi skor.

Pengurangan risiko uga winates sacara absolut. Peserta wiwit saka baseline sing rendah, 3,6 ± 2,9 %, dadi penurunan 0,45 % poin iku owahan cilik saka titik wiwitan sing wis rendah. Iki perkiraan saka kalkulator, dudu penurunan nyata ing kejadian.

Sepira Kokoh Bukti Iki?

Iki trial manusia acak double‑blind, desainé luwih kuat tinimbang studi kewan utawa data observasional. Nanging ana sawetara watesan sing kudu dipertimbangaké.

Cilik. Sawisé 61 wong dirandomisasi (33 entuk suplemen, 28 kontrol), mung 43 sing ngrampungaké loro kunjungan studi (24 vs 19). Iki kira‑kira 30 % peserta ilang, sing bisa mbengkokaké asil yen wong sing metu beda karo sing tetep.

Sponsor melu. Miturut pernyataan konflik kepentingan, salah siji penulis pegawai NOVOS Labs, lan penulis senior Christian Heiss nampa dana riset saka NOVOS Labs. Keterlibatan industri ora mbatalaké trial, nanging dadi alesan supaya pengin replikasi mandiri.

Populasi sehat lan risiko rendah. Temuan ing wong diwasa sing katon sehat bisa uga ora bisa ditrapaké kanggo wong sing nduwèni hipertensi, diabetes, utawa penyakit kardiovaskular sing wis ana.

Hasil surrogate. FMD lan PWV sing luwih apik iku tandha positif, nanging trial iki ora dirancang utawa cukup kuat kanggo nuduhaké penurunan kejadian kardiovaskular.

Bahan campuran. Kanthi 12 bahan digabung, studi ora bisa nemtokake bahan endi sing dadi penyebab efek, yen ana siji wae.

Apa Iki Dudu

Sanajan labelé "longevity powder", iki dudu bukti anti‑penuaan biologis utawa umur panjang. Makalah iki ngukur fungsi vaskuler lan tekanan darah. Ora nglaporake jam epigenetik, mortalitas, utawa umur panjang. Penulis nerangake formulasi iki nyasarake jalur sing relevan karo penuaan vaskuler, lan kerangka kuwi mung hipotesis mekanisme, dudu bukti yèn penuaan melambat.

Abstrak uga nyebutake penilaian vaskuler akut sawise dosis, nanging asil utama sing dilaporaké yaiku efek 6 bulan.

Kesimpulan Praktis

Dosis lan wektu: Abstrak nerangake panggunaan saben dina nganti 6 bulan nanging ora nyebutake ukuran sajian utawa wektu dina. Tindakake pandhuan label produk lan delengen teks lengkap (PMC13730552) kanggo protokol. Aja nganggep luwih akeh luwih apik.

Sapa sing bisa nganggep iki relevan: Wong diwasa sing umume sehat lan wis nindakake dasar‑dasar (olahraga, pola makan, turu, ora ngrokok) lan penasaran karo strategi tambahan kanggo kesehatan vaskuler. Sanajan kanggo wong iki, bukti mung siji trial cilik sing disokong sponsor.

Sapa sing kudu ati‑ati utawa ngindhari:

  • Wong sing ngonsumsi obat tekanan darah, amarga efek penurunan tambahan bisa kedadeyan. Iki precaution umum, dudu sing diuji ing makalah.
  • Sapa wae sing nganggo obat resep, hamil utawa nyusu, utawa duwe kondisi medis, kudu mriksa dhaptar bahan karo dokter dhisik.
  • Sapa wae sing ngarepake suplemen bisa ngganti statin, antihipertensi, utawa perubahan gaya urip. Trial iki ora ndhukung iku, lan lipid ora berubah.
  • Sapa wae sing ngarepake efek anti‑penuaan sing wis dibuktikaké. Trial iki ora nguji kuwi.

Ringkesan

Trial iki ngasilaké sinyal sing cukup nyenengaké: bubuk multi‑bahan dikaitaké karo fungsi endotel luwih apik, kekakuan arteri mudhun, lan tekanan darah sistolik luwih rendah sajrone enem wulan ing wong diwasa sehat, tanpa owah‑owahan kolesterol. Nanging sampel cilik, akeh peserta metu, produsen nyedhiyakake dana, lan asil mung penanda surrogate. Langkah sabanjuré yaiku trial sing luwih gedhé, mandiri, lan luwih suwe sing kalebu populasi risiko luwih dhuwur lan paling ora ngurai bahan endi sing penting.

Sources: PubMed 42979377 | DOI 10.1093/ehjopen/oeag157 | Trial registration NCT06145087

Artikel iki kanggo informasi waé lan dudu saran medis.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

**Approach:** Conceptual metaphor. **Palette:** Bold color field (teal).

A single flexible garden hose, shot from a low three-quarter angle, lies coiled against a saturated teal seamless backdrop. One half of the hose is pale and wrinkled, with a stiff, cracked rubber texture and a visible kink. The other half is supple, glossy and smoothly curved. A thin stream of water arcs from the open end, catching the light. Soft, large-source studio light comes from the upper left and casts gentle, neutral grey shadows with no blue cast. A small electric green brass fitting, with a clean metallic sheen, sits where the two halves meet. The shallow depth of field blurs the coils in the foreground. The mood is quietly doubtful but curious, as if the result is promising and still unproven. There is no text anywhere in the frame.
longevity

Magnesium Ngeredam Kekakuan Arteri Sawisé 6 Wulan—Nanging Ana Uji Null

BY DR. SYNAPSE ·

Sajeroning 12 minggu, magnesium ora nambah apa‑apa sing kawruh babagan kekakuan arteri. Ing minggu kaping‑24, uji coba acak 52 wong nemokake kecepatan gelombang nadi mundhak 1,0 m/s dibandhingake placebo, tanpa owah‑owahan tekanan darah. Iki asil sing narik kawigaten kanggo sapa wae sing kepengin mangerteni penuaan vaskular. Nanging, pamulangan sing luwih gedhe ing 2022 saka tim sing padha, sing nyoba 164 wong lan telung bentuk magnesium, ora nemokake efek signifikan. Kene dhèskripsi saka studi asli, kelemahane, lan apa sing kudu dipikirake saka bukti sing kontradiktif.

Approach 3, the human outcome, in palette D, a bold color field.

Close-up of an older adult's bare upper arm, seen from a slightly high three-quarter angle, with a blood pressure cuff wrapped snugly above the elbow. The cuff is matte graphite grey with a coiled rubber tube trailing out of frame. The arm shows real skin texture, freckles and fine creases, and the face is out of frame. The backdrop is a saturated, flat tomato-red wall. A small electric green LED glows on the cuff's digital monitor at the edge of the frame, with its display blurred and unreadable. Soft, even studio light comes from the left, with gentle shadows and no blue cast. Shallow depth of field keeps the cuff edge and skin pores sharp. The mood is calm, clinical and quietly hopeful.
supplements

NMN lan Tekanan Darah: Ringkesan 10 Uji Gabungan, Penurunan Terbanyak ing Umur >60

BY NOVA CHEN ·

Meta‑analisis anyar ing *Nutrients* nggabungake 10 uji acak NMN kanggo ndeleng apa suplemen iki bisa mengaruhi tekanan darah. Saka 349 peserta, NMN nurunake tekanan diastolik kira‑kira 2,15 mmHg, dene perubahan sistolik ora signifikan. Ing wong umur 60 taun utawa luwih, tekanan sistolik mudhun kira‑kira 3,94 mmHg. Nanging ukuran sampel cilik lan model analisis sing prasaja, mula bukti isih dhasar lan kudu dipriksa maneh. NMN ora bisa diganti obat tekanan darah.

Approach 3, the human outcome, in palette B, warm.

Low three-quarter rear angle, shot with a 50mm lens at shallow depth of field. A middle-aged person's forearm and hand grip a loaded barbell mid-deadlift, the tendons and the muscle of the forearm clearly defined, with chalk dust hanging in the air. Their face is out of frame. The setting is a plain home garage gym with a rubber floor and a rack softly blurred in the background. Low golden-hour sunlight comes through an open roll-up door and rakes across the skin and the knurled steel, casting long warm shadows. Amber, copper and honey tones dominate, with matte black plates for contrast. A tiny electric green silicone wristband or a small green pen injector resting on a nearby shelf adds a subtle accent. The mood is determined, quiet and hopeful.
metabolism

Bab Tirzepatide: Angkat Beban Nglindhungi 1,1 kg Massa Otot

BY REX MERIDIAN ·

Tirzepatide bisa ngilangi luwih saka 22 kg ing 40 minggu, nanging uga nyedhot jaringan otot lan nyuda kekuwatan. Siji uji coba acak karo 120 wong mriksa apa angkat beban telung kali seminggu isa nglindhungi otot. Penurunan lemak tetep podho, nanging grup sing ngangkat beban mung ilang kira‑kira 1,1 kg jaringan otot. Kekuwatan mudhun ing grup obat waé lan nambah ing grup sing ngangkat beban. Iki angka‑angka lan tegesé kanggo sing nganggo Mounjaro utawa Zepbound.

Approach: human outcome. Palette: natural.

Close, low-angle shot of an older adult's bare lower leg and bare feet resting on crisp white hospital bed linen, with a soft, out-of-focus window in the background. The camera sits at mattress level and looks along the calf toward the ankle. Face is not visible. A small ultrasound probe coated in clear gel presses against the back of the knee. The operator's gloved hand enters from the frame edge. Soft overcast daylight from the window gives skin tones a warm, realistic look. Around the bed, a sprig of fresh rosemary and a few purple-green ashwagandha leaves sit on a wooden bedside tray. The leaves provide plant-green accents, along with one small electric green sensor light on a monitor. Palette: natural greens, wood browns and warm skin. Mood: quiet, careful and hopeful.
supplements

PB125: Campuran Herbal Nrf2 sing Njaga Fungsi Arteri Nalika Istirahat Ing Papan

BY NOVA CHEN ·

Aktivator botani Nrf2 sing dijenengi PB125, digawe saka rosemary, ashwagandha, lan luteolin, saiki wis diuji ing uji coba double‑blind cilik marang manungsa. Ing 24 wong tuwa, dosis 200 mg/hari sajrone rong minggu nambah FMD brachial saka 2,8 % dadi 3,8 % lan FMD popliteal saka 1,5 % dadi 2,3 %. Nalika nglakoni lima dina istirahat ing papan, campuran iki njaga fungsi arteri lan kadar antioksidan dibandhingake karo plasebo. Wong enom ora nambah FMD dhasar, sanajan PB125 nglindhungi FMD popliteal nalika imobilisasi sikil. Kanthi mung 44 peserta lan ukuran surrogate, iki isyarat sing nyenengake, dudu bukti manfaat klinis.

This page is available in